Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how BioStem Technologies, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $47.48M | $301.83M | $16.69M | $6.88M | $4.34M | $2.52M | $2.63M | $1.02M | $328,528 | $592,297 |
| Revenue Growth? | -84.3% | +1708.9% | +142.7% | +58.4% | +72.1% | -4.1% | +158.6% | +209.6% | -44.5% | 0.0% |
| Cost of Revenue? | $3.26M | $13.75M | $1.26M | $881,754 | $1.47M | $1.27M | $1.32M | $602,011 | $149,671 | $359,508 |
| Gross Profit? | $44.22M | $287.86M | $15.42M | $5.99M | $2.87M | $1.25M | $1.31M | $415,181 | $178,857 | $232,789 |
| Gross Margin? | +93.1% | +95.4% | +92.4% | +87.2% | +66.0% | +49.6% | +49.8% | +40.8% | +54.4% | +39.3% |
| Operating Expenses? | $44.91M | $256.66M | $23.20M | $10.67M | $4.47M | $3.09M | $7.04M | $8.18M | $5.01M | $3.62M |
| Operating Income? | -$689,147 | $31.20M | -$7.78M | -$4.68M | -$1.61M | -$1.84M | -$5.73M | -$7.77M | -$4.83M | -$3.38M |
| EBITDA? | -$469,730 | $31.49M | -$7.55M | -$6.52M | -$601,997 | -$2.25M | -$5.38M | -$7.28M | -$4.59M | -$3.25M |
| Income Before Tax | -$389,646 | $30.61M | -$8.48M | -$7.11M | -$1.41M | -$2.37M | -$6.35M | -$7.74M | -$4.86M | -$3.57M |
| Income Tax Expense | $6.19M | -$1.27M | $0 | $0 | $0 | $0 | $667,986 | $0 | $13,325 | $25,977 |
| Net Income? | -$6.58M | $31.88M | -$8.48M | -$7.07M | -$1.45M | -$2.39M | -$6.38M | -$7.59M | -$4.84M | -$3.56M |
| EPS? | $-0.39 | $1.95 | $-0.62 | $-0.62 | $-0.12 | $-0.26 | $-0.69 | $-0.94 | $-0.95 | $-1.07 |
| Diluted EPS? | $-0.39 | $1.47 | $-0.62 | $-0.62 | $-0.12 | $-0.26 | $-0.69 | $-0.94 | $-0.95 | $-1.07 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality